- call +1-201-465-4211
- email sales@mrinsights.biz
Digital therapeutics refers to health or social care interventions delivered through a smart device to support healthy behaviors and provide therapeutic effects. Digital therapies/programs are cost-effective and have the potential to improve patient engagement and bring a substantial change in patients’ health. Owing to these advantages, digital therapeutics is increasingly being prescribed to help manage long-term conditions such as diabetes, insomnia, and asthma.
Scope of the Report:
This report focuses on the Digital Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Digital Therapeutics Market growth is driven by the incidence of preventable chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and a number of benefits offered by digital therapeutics, such as their abilities to induce behavioral change, improve drug adherence, patient convenience, and user-friendliness. Furthermore, government initiatives to support the development and adoption of digital therapeutics solutions also provide an impetus to the growth of this market. The relatively untapped Asia-Pacific market and unexplored therapeutic applications have opened an array of opportunities for the growth of the market. However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the growth of this market.
The worldwide market for Digital Therapeutics is expected to grow at a CAGR of roughly 30.3% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Proteus Digital Health, Inc.
Omada Health, Inc.
Welldoc, Inc.
Livongo Health
Noom Inc.
Ginger.Io, Inc.
Propeller Health
2morrow Inc.
Canary Health Inc.
Mango Health Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
B2C
B2B
Market Segment by Applications, can be divided into
Preventive
Treatment/Care
There are 15 Chapters to deeply display the global Digital Therapeutics market.
Chapter 1, to describe Digital Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Digital Therapeutics, with sales, revenue, and price of Digital Therapeutics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Digital Therapeutics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Digital Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Digital Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Digital Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 B2C
1.2.2 B2B
1.3 Market Analysis by Applications
1.3.1 Preventive
1.3.2 Treatment/Care
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Proteus Digital Health, Inc.
2.1.1 Business Overview
2.1.2 Digital Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Proteus Digital Health, Inc. Digital Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Omada Health, Inc.
2.2.1 Business Overview
2.2.2 Digital Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Omada Health, Inc. Digital Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Welldoc, Inc.
2.3.1 Business Overview
2.3.2 Digital Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Welldoc, Inc. Digital Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Livongo Health
2.4.1 Business Overview
2.4.2 Digital Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Livongo Health Digital Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Noom Inc.
2.5.1 Business Overview
2.5.2 Digital Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Noom Inc. Digital Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Ginger.Io, Inc.
2.6.1 Business Overview
2.6.2 Digital Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Ginger.Io, Inc. Digital Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Propeller Health
2.7.1 Business Overview
2.7.2 Digital Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Propeller Health Digital Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 2morrow Inc.
2.8.1 Business Overview
2.8.2 Digital Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 2morrow Inc. Digital Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Canary Health Inc.
2.9.1 Business Overview
2.9.2 Digital Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Canary Health Inc. Digital Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Mango Health Inc.
2.10.1 Business Overview
2.10.2 Digital Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Mango Health Inc. Digital Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Digital Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Digital Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Digital Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Digital Therapeutics Manufacturer Market Share in 2017
3.3.2 Top 6 Digital Therapeutics Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Digital Therapeutics Market Analysis by Regions
4.1 Global Digital Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Digital Therapeutics Sales and Market Share by Regions (2013-2018)
4.1.2 Global Digital Therapeutics Revenue and Market Share by Regions (2013-2018)
4.2 North America Digital Therapeutics Sales and Growth Rate (2013-2018)
4.3 Europe Digital Therapeutics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Digital Therapeutics Sales and Growth Rate (2013-2018)
4.5 South America Digital Therapeutics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Digital Therapeutics Sales and Growth Rate (2013-2018)
5 North America Digital Therapeutics by Countries
5.1 North America Digital Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 North America Digital Therapeutics Sales and Market Share by Countries (2013-2018)
5.1.2 North America Digital Therapeutics Revenue and Market Share by Countries (2013-2018)
5.2 United States Digital Therapeutics Sales and Growth Rate (2013-2018)
5.3 Canada Digital Therapeutics Sales and Growth Rate (2013-2018)
5.4 Mexico Digital Therapeutics Sales and Growth Rate (2013-2018)
6 Europe Digital Therapeutics by Countries
6.1 Europe Digital Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Europe Digital Therapeutics Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Digital Therapeutics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Digital Therapeutics Sales and Growth Rate (2013-2018)
6.3 UK Digital Therapeutics Sales and Growth Rate (2013-2018)
6.4 France Digital Therapeutics Sales and Growth Rate (2013-2018)
6.5 Russia Digital Therapeutics Sales and Growth Rate (2013-2018)
6.6 Italy Digital Therapeutics Sales and Growth Rate (2013-2018)
7 Asia-Pacific Digital Therapeutics by Countries
7.1 Asia-Pacific Digital Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Digital Therapeutics Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Digital Therapeutics Revenue and Market Share by Countries (2013-2018)
7.2 China Digital Therapeutics Sales and Growth Rate (2013-2018)
7.3 Japan Digital Therapeutics Sales and Growth Rate (2013-2018)
7.4 Korea Digital Therapeutics Sales and Growth Rate (2013-2018)
7.5 India Digital Therapeutics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Digital Therapeutics Sales and Growth Rate (2013-2018)
8 South America Digital Therapeutics by Countries
8.1 South America Digital Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America Digital Therapeutics Sales and Market Share by Countries (2013-2018)
8.1.2 South America Digital Therapeutics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Digital Therapeutics Sales and Growth Rate (2013-2018)
8.3 Argentina Digital Therapeutics Sales and Growth Rate (2013-2018)
8.4 Colombia Digital Therapeutics Sales and Growth Rate (2013-2018)
9 Middle East and Africa Digital Therapeutics by Countries
9.1 Middle East and Africa Digital Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Digital Therapeutics Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Digital Therapeutics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Digital Therapeutics Sales and Growth Rate (2013-2018)
9.3 UAE Digital Therapeutics Sales and Growth Rate (2013-2018)
9.4 Egypt Digital Therapeutics Sales and Growth Rate (2013-2018)
9.5 Nigeria Digital Therapeutics Sales and Growth Rate (2013-2018)
9.6 South Africa Digital Therapeutics Sales and Growth Rate (2013-2018)
10 Global Digital Therapeutics Market Segment by Type
10.1 Global Digital Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Digital Therapeutics Sales and Market Share by Type (2013-2018)
10.1.2 Global Digital Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 B2C Sales Growth and Price
10.2.1 Global B2C Sales Growth (2013-2018)
10.2.2 Global B2C Price (2013-2018)
10.3 B2B Sales Growth and Price
10.3.1 Global B2B Sales Growth (2013-2018)
10.3.2 Global B2B Price (2013-2018)
11 Global Digital Therapeutics Market Segment by Application
11.1 Global Digital Therapeutics Sales Market Share by Application (2013-2018)
11.2 Preventive Sales Growth (2013-2018)
11.3 Treatment/Care Sales Growth (2013-2018)
12 Digital Therapeutics Market Forecast (2018-2023)
12.1 Global Digital Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 Digital Therapeutics Market Forecast by Regions (2018-2023)
12.2.1 North America Digital Therapeutics Market Forecast (2018-2023)
12.2.2 Europe Digital Therapeutics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Digital Therapeutics Market Forecast (2018-2023)
12.2.4 South America Digital Therapeutics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Digital Therapeutics Market Forecast (2018-2023)
12.3 Digital Therapeutics Market Forecast by Type (2018-2023)
12.3.1 Global Digital Therapeutics Sales Forecast by Type (2018-2023)
12.3.2 Global Digital Therapeutics Market Share Forecast by Type (2018-2023)
12.4 Digital Therapeutics Market Forecast by Application (2018-2023)
12.4.1 Global Digital Therapeutics Sales Forecast by Application (2018-2023)
12.4.2 Global Digital Therapeutics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Digital Therapeutics Picture
Table Product Specifications of Digital Therapeutics
Figure Global Sales Market Share of Digital Therapeutics by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
